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Intermediate trophoblasts, a subtype of trophoblastic tissue arising
from the cytotrophoblast can give rise to four distinct lesions which in-
clude the exaggerated placental site (EPS), placental site nodule (PSN),
placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic
tumor (ETT). Rare and usually benign, these tumors reveal malignant
potential in 10–15% of cases. Two particularly malignant lesions include
the placental site trophoblastic tumor and the epithelioid trophoblastic
tumor that arise from the chorion laeve (Shih and Kurman, 2001; Soper
et al., 2004). The average age at time of diagnosis is 30 years with a
range of 19–62 years (Schulz-Bischof and Scheidel, 2007). Most com-
monly, these patients present with abnormal uterine bleeding and low
serum levels of β-HCG, preceded by a normal pregnancy or a spontane-
ous abortion (Baergen et al., 2006; Kurman, 1991). Diagnosis can be dif-
ﬁcult and delayed. By the time of patient presentation, frequently there
is already evidence of metastatic disease. Pneumothorax is a rare form
of initial presentation in the patient with metastatic lung disease
(Biran et al., 1992).Case
A 47 year old African-American multipara (G4P3013) woman with-
out any signiﬁcant past medical history presented to the emergency
room with complaints of worsening shortness of breath and right-
sided chest pain. She reported that this episodewas similar to a previous
episode 15 months ago when she presented to a different hospital at⁎ Corresponding author at: 2500 North State Street, Jackson, MS 39216, USA.
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made. She had a chest tube placed at that time followed by a 4-day hos-
pitalization prior to release with no further evaluation. The patient ac-
knowledged a history of cigarette smoking and denied a history of
tuberculosis, or any prior lung disease.
Evaluation in the emergency room revealed radiologic evidence of a
recurrent pneumothorax (Fig. 1). A chest tube was placed and she was
admitted to the cardiothoracic surgery service. On admission, she
had a computed tomography scan which revealed multiple cystic
lesions in her lungs, a hypo-dense lesion in her liver, and a pelvic
mass concerning for a necrotic ﬁbroid. Internal medicine, Obstetrics/
Gynecology and Interventional Radiology were consulted.
She underwent trans-bronchial biopsies and bronchoalveolar la-
vage, which returned non-diagnostic. Serum studies for infectious pro-
cesses also returned negative. The pulmonary service recommended
surgical lung biopsy for diagnosis of a pulmonary process. Given the
characteristics of the lesions, the leading differentials were between
metastatic processes versus septic emboli.
To the Gynecology consult service, the patient reported a 2-year his-
tory of irregular vaginal bleeding. She stated that recently the bleeding
had been lighter than in the past. She stated that for the past two
years she had also noted a slow increase in abdominal girth and a
15 lb weight gain in the past 5 months.
Also, the patient gave a history of having a positive urine pregnancy
test during an annual exam3months ago. She had a positive urine preg-
nancy and quantitative HCG blood test two years ago prior to that exam
at her family medicine clinic, which was not further evaluated. The pa-
tient reported that her last pregnancy was 12 years ago, which resulted
in the cesarean delivery of a termmale infant. She had not been on any
form of contraception since.
An endometrial biopsywas performedwhich returnedwith features
of both an epithelioid trophoblastic tumor and a placental site tropho-
blastic tumor, making the more general diagnosis of an intermediate
trophoblastic tumor appropriate. A β-HCG obtained at the time of the
endometrial biopsy was noted to be 59.7 IU/L. An IR biopsy of the liver
lesion was found to be consistent withmetastatic trophoblastic disease.
She underwent exploratory laparotomywith total abdominal hysterec-
tomy, bilateral salpingo-oophorectomy and omentectomy on day 12 of
her hospital admission. No gross disease other than a necrotic uterus
was noted in the abdomen, and close inspection of the liver revealed
no gross exophytic lesions. At completion, no residual disease burden
was noted in the abdomen or pelvis.-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1.A. Right pneumothorax. B.Multiple cystic lesions of varying size in both lungs withmildly thickenedwalls. C. Enlarged uteruswith heterogeneous enhancement. D.Metastatic liver
lesion.
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sults of the surgical specimen conﬁrmed initial diagnosis obtained by
endometrial biopsy. Her ﬁnal diagnosis was FIGO Stage IV intermediate
trophoblastic disease.
Her right pneumothorax had been resolved by postoperative day 5
and the chest tube was removed. However, the patient's postoperative
course was complicated by a left sided pneumothorax for which she
underwent left sided chest tube placement by IR on postoperative
day 6. Prior to discharge the patient underwent placement of a
chemoport and left pigtail chest tube. Her pneumothoraces were be-
lieved to be secondary to the extensive pulmonary metastatic disease.
She was discharged from the hospital on postoperative day 15 with no
further sequelae.
She underwent a VATS procedure with cardiothoracic surgery in
June 2013 after her ﬁrst cycle of chemotherapy due to persistent pneu-
mothorax on the left side as well as recurrent pleural effusions on the
right side, which were treated with left chest tube placement, right
lung decortication and pleurodesis.
She underwent chemotherapy treatment with 10 cycles of EMA-CO
(etoposide, methotrexate, actinomycin D, cyclophosphamide and vin-
cristine) from May 2013 to November 2013. The patient was then
noted to have an increasing HCG of 3.3 IU/L in February 2014 to 8.3 in
May 2014 with negative imaging. The patient then underwent 6 cycles
of 2nd line EMACO, last on 8/26/14. On 9/9/14, her HCG was 2.3 IU/L,
however, has now started rising again, most recently 21 IU/L in Novem-
ber 2014. The patient tolerated the cycles of chemotherapy well with
minimal side effects; however, she has had persistent pulmonary com-
plaints of a dry cough and recently pulmonary abscesses. Her course has
been followed by B-HCG as HPL was not available at our institution and
imaging was performed for rising HCG or worsening symptoms.Discussion
Trophoblastic tumors remain a rare and elusive disease process. Di-
agnosis of these tumors can prove difﬁcult, asmost often the symptoms
at the time of presentation are often vague. Diagnosis of this rare form of
trophoblastic disease has proven difﬁcult due to very few cases having
been reported in literature.
As proven to be the case in our scenario, a thorough history of the
patient's presentation can prove useful in establishing a comprehensive
list of differential diagnoses. Pneumothorax is a rare presentation of
GTN and still a more uncommon complicationwithmetastatic lung dis-
ease of any etiology (Aggarwal et al., 2010; Brufman et al., 1977).
In the setting of abnormal uterine bleeding and a positive urine
pregnancy test, consideration should be given to the possibility of
gestational trophoblastic diseases. In our patient, an earlier diagnosis
could have been achieved if the patient was referred to an Ob/Gyn for
evaluation.
Further separating this case from previously published case reports
are the patient's histologic ﬁndings. This intermediate trophoblastic
tumor is composed of two cell populations (Fig. 2). One population is
the chorionic-type intermediate trophoblast, and the other is the im-
plantation site intermediate trophoblast. The chorionic-type intermedi-
ate trophoblast comprises the epithelioid trophoblastic component of
this tumor, and the implantation site intermediate trophoblast com-
prises the placental site trophoblastic component of this tumor.
Her antecedent pregnancy having been 12 years prior to her presen-
tation is also an uncommon occurrencewith placental site trophoblastic
tumors. Very few studies are published regarding mortality risks in pa-
tients with these tumors. To date, the only correlate that has been found
betweenoverall survival rates of the patient has been FIGO staging,with
Fig. 2.A.An area of geographic necrosis is presentwith islands of tumor cells. B. The epithelioid trophoblastic portion of this tumor is composed of relatively uniform epithelioid cells. These
cells aremononuclear with abundant eosinophilic cytoplasm. Occasional populations of tumor cells contain clear, glycogen-rich cytoplasm. C. Additionally there is a second population of
cells, which comprise the placental site trophoblastic component of this tumor. These cells are large and polygonal with irregular, hyperchromatic nuclei. There are characteristic areas of
myoinvasion present.
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pregnancy played no role in survival rates (Baergen et al., 2006).
To the best of our knowledge, our patient is the ﬁfth reported case
with the presentation of a spontaneous pneumothorax (Schulz-
Bischof and Scheidel, 2007). None of the other four cases had an ante-
cedent pregnancy occurring longer than two years prior to presentation
with this constellation of symptoms. Also, unlike previous case reports,
the ﬁnal pathologic diagnosis in our patient displayed features of both
an epithelioid trophoblastic tumor and a placental site trophoblastic
tumor, a ﬁnding that has not been previously reported.
A placental site trophoblastic tumor, though a rare form of GTN, can
prove difﬁcult to treat as we have learned in the course of our patient. It
requires a multidisciplinary approach. Though the patient may have an
initial response to chemotherapy, the pulmonary sequelae may persist
as in the case of our patient.
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